Related Experiment Video
Updated: Jun 8, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
The increased cardiovascular risk in rheumatoid arthritis: when does it start?
Cardiovascular risk in early rheumatoid arthritis (RA) appears similar to the general population, contrary to established RA risks. Further research is needed to reconcile these findings with existing cardiovascular disease literature.
Area of Science:
- Rheumatology
- Cardiology
- Vascular Biology
Background:
- Established rheumatoid arthritis (RA) significantly increases cardiovascular risk.
- Limited data exist on cardiovascular risk in early RA.
- Carotid intima-media thickness (cIMT) assesses preclinical atherosclerosis and predicts cardiovascular events.
Discussion:
- A prospective study using cIMT in early RA patients found no increased baseline cardiovascular risk.
- cIMT progression in early RA patients was comparable to the general population.
- These findings contrast with established RA cardiovascular risk literature.
Key Insights:
- Early rheumatoid arthritis may not confer an immediate heightened cardiovascular risk.
- Carotid intima-media thickness progression did not differ between early RA patients and controls.
- The study highlights a discrepancy with existing literature on RA and cardiovascular disease.
Outlook:
- Further large-scale investigations are essential to clarify the cardiovascular risk profile in early RA.
- Reconciling these findings with existing literature is crucial for clinical practice.
- Continued research will refine understanding of RA's long-term vascular impact.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease III: Medical Management